Percutaneous closure of patent foramen ovale with a novel FlatStent™

References

• Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation107(1), 5–9 (2003).
   PubMed Web of Science ®Google Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc.59(1), 17–20 (1984).
   PubMed Web of Science ®Google Scholar
• Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J. Am. Coll. Cardiol.38(3), 613–623 (2001).
   PubMed Web of Science ®Google Scholar
• Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am. Heart J.130(5), 1083–1088 (1995).
   PubMed Web of Science ®Google Scholar
• Germonpre P, Hastir F, Dendale P, Marroni A, Nguyen AF, Balestra C. Evidence for increasing patency of the foramen ovale in divers. Am. J. Cardiol.95(7), 912–915 (2005).)
   PubMed Web of Science ®Google Scholar
• Chen GP. Patent foramen ovale and the platypnea–orthodeoxia syndrome. Cardiol. Clin.23(1), 85–89 (2005).
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Nedeltchev K, Lagger F et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology65(9), 1415–1418 (2005).
   PubMed Web of Science ®Google Scholar
• Reisman M, Christofferson RD, Jesurum J et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J. Am. Coll. Cardiol.45(4), 493–495 (2005).
   PubMed Web of Science ®Google Scholar
• Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N. Engl. J. Med.357, 2262–2268 (2007).
   PubMed Web of Science ®Google Scholar
• Overell JR, Bone, I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case–control studies. Neurology55, 1172–1179 (2000).
   PubMed Web of Science ®Google Scholar
• Mas JL, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N. Engl. J. Med.345, 1740–1746 (2001).
   PubMed Web of Science ®Google Scholar
• Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am. J. Med.109, 456–462 (2000).
   PubMed Web of Science ®Google Scholar
• Meissner I, Khandheria BK, Heit JA et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J. Am. Coll. Cardiol.47(2), 440–445 (2006).
   PubMed Web of Science ®Google Scholar
• Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J. Am. Coll. Cardiol.49(7), 797–802 (2007).
   PubMed Web of Science ®Google Scholar
• Amarenco P, Cohen A, Tzourio C et al. Atherosclerotic disease of aortic arch and the risk of ischemic stroke. N. Engl. J. Med.331, 1474–1479 (1994).
   PubMed Web of Science ®Google Scholar
• Steinberg DH, Pichard AD, Satler LF et al. Patent foramen ovale closure: past, present and future. Expert Rev. Cardiovasc. Ther.5(5), 881–891 (2007).
   PubMedGoogle Scholar
• Wilmshurst PT, Nightinqale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons. Lancet356(9242), 1648–1651 (2000).
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Nedeltchev K, Meier B. Patent foramen ovale closure: a new therapy for migraine. Catheter. Cardiovasc. Interv.69(2), 277–284 (2007).
   PubMed Web of Science ®Google Scholar
• Lamy C, Giannesini C, Zuber M et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-AS Study. Stroke33(3), 706–711 (2002).
   PubMed Web of Science ®Google Scholar
• Del Sette M, Angeli S, Leandri M et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case control study. Cerebrovasc. Dis.8(6), 327–330 (1998).
   PubMed Web of Science ®Google Scholar
• Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Wolta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology52(8), 1622–1625 (1999).
   PubMed Web of Science ®Google Scholar
• Domitrz I, Mieszkowski J, Kaminska A. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache47(9), 1311–1318 (2007).
   PubMedGoogle Scholar
• Dowson A, Mullen MJ, Peatfield R et al. Migraine Intervention With STARFlex Technology (MIST) trial. A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation117, 1397–1404 (2008).
   PubMed Web of Science ®Google Scholar
• Wilmshurst P, Bryson P. Relationship between the clinical features of neurological decompression illness and its causes. Clin. Sci. (Lond.)99, 65–75 (2000).
   PubMedGoogle Scholar
• Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J. Interv. Cardiol.16, 39–42 (2003).
   PubMedGoogle Scholar
• Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt associated migraine responds favorably to atrial septal repair: a case control study. Stroke.37, 430–434 (2006).
   PubMed Web of Science ®Google Scholar
• Kimmelstiel C, Gange C, Thaler D. Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc. Interv.69, 740–746 (2007).
   PubMedGoogle Scholar
• Rigatelli G, Cardaioli P, Braggion G et al. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia. Catheter Cardiovasc. Interv.70, 429–433 (2007).
   PubMedGoogle Scholar
• Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology66, 765–767 (2006).
   PubMed Web of Science ®Google Scholar
• Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation86(6), 1902–1908 (1992).
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Windecker S, Wahl A et al. Percutaneous closure of patent foramen ovale: impact of device on safety and efficacy. Heart90(2), 186–190 (2004).
   PubMed Web of Science ®Google Scholar
• Mullen MJ, Hildick-Smith D, De Giovanni JV et al. BioSTAR Evaluation Study (BEST): a prospective, multicenter, Phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation114(18), 1962–1967 (2006).
   PubMed Web of Science ®Google Scholar
• Windecker S, Wahl A, Chatterjee T et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long term risk of recurrent thromboembolic events. Circulation101(8), 893–898 (2000).
   PubMed Web of Science ®Google Scholar
• Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc. Interv.68(5), 741–746 (2006).
   PubMed Web of Science ®Google Scholar
• Alameddine F, Block PC. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry. Catheter Cardiovasc. Interv.62(4), 512–516 (2004).
   PubMed Web of Science ®Google Scholar
• Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J. Am. Coll. Cardiol.48(1), 161–169 (2006).
   PubMed Web of Science ®Google Scholar
• Jux C, Wohlsein P, Bruegmann M, Zutz M, Franzbach B, Bertram H. A new biological matrix for septal occlusion. J. Interv. Cardiol.16(2), 149–152 (2003).
   PubMedGoogle Scholar
• Büscheck F, Sievert H, Kleber F et al. Patent foramen ovale using the Premere device: the results of the CLOSEUP trial. J. Interv. Cardiol.19(4), 328–333 (2006).
   PubMedGoogle Scholar